|Bid||137.00 x 100|
|Ask||138.77 x 100|
|Day's Range||135.69 - 139.02|
|52 Week Range||95.14 - 139.02|
|PE Ratio (TTM)||118.45|
|Earnings Date||Jul 26, 2017 - Jul 31, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||150.00|
American Century Ultra Fund is on a decent roll. Here's how the fund managers aim to stay hot.
A Relative Strength Rating upgrade for Glaukos shows improving technical performance. Will it continue?
Abiomed Inc. (ABMD), a leading developer, manufacturer and marketer of medical products, reported fourth-quarter fiscal 2017 earnings of 33 cents per share, which were in line with the Zacks Consensus Estimate.